Artac M - Search Results

1

Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.

Eren OO, Artac M, Boruban MC, Yavas O, Arslan U, Basaranoglu M. Eren OO, et al. Among authors: artac m. Med Oncol. 2009 Dec;26(4):386-92. doi: 10.1007/s12032-008-9133-4. Epub 2008 Nov 20. Med Oncol. 2009. PMID: 19021003 Clinical Trial.

2

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Faivre-Finn C, Reck M, Vansteenkiste J, Spigel DR, Wadsworth C, Melillo G, Taboada M, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. N Engl J Med. 2018 Dec 13;379(24):2342-2350. doi: 10.1056/NEJMoa1809697. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280658 Free article. Clinical Trial.

3

The acute effect of tropisetron on ECG parameters in cancer patients.

Yavas O, Yazici M, Eren O, Boruban C, Artac M, Genc M. Yavas O, et al. Among authors: artac m. Support Care Cancer. 2008 Sep;16(9):1011-5. doi: 10.1007/s00520-007-0400-2. Epub 2008 Feb 1. Support Care Cancer. 2008. PMID: 18239945

4

Leptin and breast cancer: an overview.

Artac M, Altundag K. Artac M, et al. Med Oncol. 2012 Sep;29(3):1510-4. doi: 10.1007/s12032-011-0056-0. Epub 2011 Aug 30. Med Oncol. 2012. PMID: 21877194 Review.

5

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs).

Artac M, Bozcuk H, Kiyici A, Eren OO, Boruban MC, Ozdogan M. Artac M, et al. Breast Cancer. 2013 Apr;20(2):174-80. doi: 10.1007/s12282-011-0322-1. Epub 2011 Dec 28. Breast Cancer. 2013. PMID: 22203581

6

Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases.

Artac M, Koral L, Toy H, Guler T, Boruban MC, Altundag K. Artac M, et al. J Oncol Pharm Pract. 2014 Apr;20(2):141-5. doi: 10.1177/1078155213480201. Epub 2013 May 14. J Oncol Pharm Pract. 2014. PMID: 23676508

7

Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.

Geredeli C, Artac M, Yildirim S, Inal A, Dede I, Guler T, Boruban MC, Koral L, Karaagac M, Zamani AG, Altinok T, Aribas O, Bozcuk H, Demirkazik A. Geredeli C, et al. Among authors: artac m. Tumour Biol. 2015 Jun;36(6):4279-85. doi: 10.1007/s13277-015-3066-2. Epub 2015 Jan 18. Tumour Biol. 2015. PMID: 25596702

8

Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma.

Geredeli C, Boruban MC, Poyraz N, Artac M, Aribas A, Koral L. Geredeli C, et al. Among authors: artac m. Case Rep Cardiol. 2015;2015:958756. doi: 10.1155/2015/958756. Epub 2015 Apr 28. Case Rep Cardiol. 2015. PMID: 26060585 Free PMC article.

9

Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab.

Artaç M, Uysal M, Karaağaç M, Korkmaz L, Er Z, Güler T, Börüban MC, Bozcuk H. Artaç M, et al. J Gastrointest Cancer. 2017 Jun;48(2):176-180. doi: 10.1007/s12029-016-9879-4. J Gastrointest Cancer. 2017. PMID: 27714653

10

Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group.

Erol C, Sendur Mehmet AN, Bilgetekin I, Garbioglu DB, Hamdard J, Akbas S, Hizal M, Arslan C, Sevinc A, Kucukarda A, Erdem D, Kahraman S, Cakir E, Demirkiran A, On S, Dogan I, Erdogan AP, Koca S, Kubilay P, Eren OO, Cilbir E, Celik E, Araz M, Ozyukseler DT, Yildirim ME, Bahceci A, Taskaynatan H, Oyman A, Deniz GI, Menekse S, Kut E, Gulmez A, Sakin A, Nayir E, Acar R, Sen E, Inal A, Turhal S, Kaya AO, Paydas S, Tastekin D, Hacibekiroglu I, Cincin I, Bilici A, Mandel NM, Dede DS, Akinci MB, Oksuzoglu B, Uncu D, Yalcin B, Artac M. Erol C, et al. Among authors: artac m. J Cancer Res Ther. 2022 Dec;18(12 Suppl 2):S347-S353. doi: 10.4103/jcrt.jcrt_1104_21. J Cancer Res Ther. 2022. PMID: 36510987 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page